Cargando…
Roles of the PI3K/AKT/mTOR signalling pathways in neurodegenerative diseases and tumours
The PI3 K/AKT/mTOR signalling pathway plays an important role in the regulation of signal transduction and biological processes such as cell proliferation, apoptosis, metabolism and angiogenesis. Compared with those of other signalling pathways, the components of the PI3K/AKT/mTOR signalling pathway...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7110906/ https://www.ncbi.nlm.nih.gov/pubmed/32266056 http://dx.doi.org/10.1186/s13578-020-00416-0 |
_version_ | 1783513165248593920 |
---|---|
author | Xu, Fei Na, Lixin Li, Yanfei Chen, Linjun |
author_facet | Xu, Fei Na, Lixin Li, Yanfei Chen, Linjun |
author_sort | Xu, Fei |
collection | PubMed |
description | The PI3 K/AKT/mTOR signalling pathway plays an important role in the regulation of signal transduction and biological processes such as cell proliferation, apoptosis, metabolism and angiogenesis. Compared with those of other signalling pathways, the components of the PI3K/AKT/mTOR signalling pathway are complicated. The regulatory mechanisms and biological functions of the PI3K/AKT/mTOR signalling pathway are important in many human diseases, including ischaemic brain injury, neurodegenerative diseases, and tumours. PI3K/AKT/mTOR signalling pathway inhibitors include single-component and dual inhibitors. Numerous PI3K inhibitors have exhibited good results in preclinical studies, and some have been clinically tested in haematologic malignancies and solid tumours. In this review, we briefly summarize the results of research on the PI3K/AKT/mTOR pathway and discuss the structural composition, activation, communication processes, regulatory mechanisms and biological functions of the PI3K/AKT/mTOR signalling pathway in the pathogenesis of neurodegenerative diseases and tumours. |
format | Online Article Text |
id | pubmed-7110906 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-71109062020-04-07 Roles of the PI3K/AKT/mTOR signalling pathways in neurodegenerative diseases and tumours Xu, Fei Na, Lixin Li, Yanfei Chen, Linjun Cell Biosci Review The PI3 K/AKT/mTOR signalling pathway plays an important role in the regulation of signal transduction and biological processes such as cell proliferation, apoptosis, metabolism and angiogenesis. Compared with those of other signalling pathways, the components of the PI3K/AKT/mTOR signalling pathway are complicated. The regulatory mechanisms and biological functions of the PI3K/AKT/mTOR signalling pathway are important in many human diseases, including ischaemic brain injury, neurodegenerative diseases, and tumours. PI3K/AKT/mTOR signalling pathway inhibitors include single-component and dual inhibitors. Numerous PI3K inhibitors have exhibited good results in preclinical studies, and some have been clinically tested in haematologic malignancies and solid tumours. In this review, we briefly summarize the results of research on the PI3K/AKT/mTOR pathway and discuss the structural composition, activation, communication processes, regulatory mechanisms and biological functions of the PI3K/AKT/mTOR signalling pathway in the pathogenesis of neurodegenerative diseases and tumours. BioMed Central 2020-04-01 /pmc/articles/PMC7110906/ /pubmed/32266056 http://dx.doi.org/10.1186/s13578-020-00416-0 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Review Xu, Fei Na, Lixin Li, Yanfei Chen, Linjun Roles of the PI3K/AKT/mTOR signalling pathways in neurodegenerative diseases and tumours |
title | Roles of the PI3K/AKT/mTOR signalling pathways in neurodegenerative diseases and tumours |
title_full | Roles of the PI3K/AKT/mTOR signalling pathways in neurodegenerative diseases and tumours |
title_fullStr | Roles of the PI3K/AKT/mTOR signalling pathways in neurodegenerative diseases and tumours |
title_full_unstemmed | Roles of the PI3K/AKT/mTOR signalling pathways in neurodegenerative diseases and tumours |
title_short | Roles of the PI3K/AKT/mTOR signalling pathways in neurodegenerative diseases and tumours |
title_sort | roles of the pi3k/akt/mtor signalling pathways in neurodegenerative diseases and tumours |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7110906/ https://www.ncbi.nlm.nih.gov/pubmed/32266056 http://dx.doi.org/10.1186/s13578-020-00416-0 |
work_keys_str_mv | AT xufei rolesofthepi3kaktmtorsignallingpathwaysinneurodegenerativediseasesandtumours AT nalixin rolesofthepi3kaktmtorsignallingpathwaysinneurodegenerativediseasesandtumours AT liyanfei rolesofthepi3kaktmtorsignallingpathwaysinneurodegenerativediseasesandtumours AT chenlinjun rolesofthepi3kaktmtorsignallingpathwaysinneurodegenerativediseasesandtumours |